EFFECT OF TRIGGER POINT RELEASE WITH IASTM ON QUADRATUS LUMBORUM IN SUBJECTS WITH NON SPECIFIC LOW BACK PAIN.
Not Applicable
Completed
- Conditions
- Health Condition 1: M628- Other specified disorders of muscle
- Registration Number
- CTRI/2019/01/017234
- Lead Sponsor
- KAHER Institute Of Physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
Subjects with non specific low back pain.
Exclusion Criteria
Open wound or any skin disease around hip and back
Subjects with hypersensitive skin
Subjects with any sensory loss or neuropathy.
Pregnancy
All contraindications of IASTM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pressure algometer <br/ ><br>Modified oswestery disability questionaier <br/ ><br>Modified schobers testTimepoint: Pre treatment and post treatment these are used to asses.
- Secondary Outcome Measures
Name Time Method Pressure algometer for painTimepoint: Before and after intervention it is used.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie trigger point release in treating non-specific low back pain?
How does IASTM compare to standard-of-care therapies for M628 muscle disorders in clinical outcomes?
Are there specific biomarkers associated with response to IASTM in Quadratus Lumborum treatment?
What adverse events are reported with IASTM for low back pain and how are they managed?
What combination therapies show potential with IASTM for non-specific low back pain management?